enGene Holdings Inc., a clinical-stage genetic medicines company, announced that Dr. Raj Pruthi will resign from his position as Chief Medical Officer, effective June 16, 2025. The company plans to redistribute his responsibilities among its existing urology and clinical experts.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250604959358) on June 04, 2025, and is solely responsible for the information contained therein.